Effect of cardiac rehabilitation and relaxation on the quality of life in patients with cardiac syndrome X

Effect of cardiac rehabilitation and relaxation on the quality of life in patients with cardiac syndrome x in hospitals affiliated to Urmia University of Medical Sciences .

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201204099422N1

Enrollment

Registered

2012-06-10

Start date

2011-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac syndrome x. Chronic ischaemic heart disease, unspecified

Interventions

Intervention 1: CR group: 8-week participation in phase III cardiac rehabilitation exercise program at home,3 times per week with 60-65% of maximum heart rate + Current treatment. Intervention 2: CR &

Lifestyle

CR group: 8-week participation in phase III cardiac rehabilitation exercise program at home,3 times per week with 60-65% of maximum heart rate + Current treatment

CR & PMR group: 8-week participation in phase III cardiac rehabilitation exercise program at home,3 times per week with 60-65% of maximum heart rate + 8-week participation in progressive muscle relaxa

PMR group: 8-week participation in progressive muscle relaxation program based on Jacobson's method, 15 minutes daily at home + Current treatment.

Control group: Current treatment

Eligibility

Sex/Gender

Female

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 30-65 year old; Women; Urmia resident; Willing to give written informed consent; Confirmed by a cardiologist to participate in exercise programs. Exclusion criteria: History of psychiatric illness; History of any other chronic illness; Presence of any physical condition for which exercise is contraindicated; Participation in moderate intensity exercise programsat least 2 times per week during the past 6 months; Participation in relaxation or meditation programs during the past 6 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Short form of QOL questionnaire (SF-36).	—

Secondary

Measure	Time frame
Anxiety and Depression. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Hospital anxiety and depression scale.;Physical activity. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Short form of international physical activity questionnaire.;Chest pain. Timepoint: After intervention. Method of measurement: Daily chest pain check list.	—

Measure

Time frame

Anxiety and Depression. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Hospital anxiety and depression scale.;Physical activity. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Short form of international physical activity questionnaire.;Chest pain. Timepoint: After intervention. Method of measurement: Daily chest pain check list.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Aram Feizi

Urmia University of Medical Sciences

aramfeizi@yahoo.com+98 44 1275 2917

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026